Neuronetics (STIM) Misses Q2 EPS by 6c ; Offers Guidance

Neuronetics (NASDAQ: STIM) reported Q2 EPS of ($0.33), $0.06 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $16.45 million versus the consensus estimate of $18.65 million.

GUIDANCE:

Neuronetics sees Q3 2024 revenue of $18.5-19.5 million, versus the consensus of $20.12 million.

Neuronetics sees FY2024 revenue of $78-80 million, versus the consensus of $79.14 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance
• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance